Literature DB >> 16912184

Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis.

Cynthia J Guidi1, Rajini Mudhasani, Kathleen Hoover, Andrew Koff, Irwin Leav, Anthony N Imbalzano, Stephen N Jones.   

Abstract

The Ini1 subunit of the SWI/SNF chromatin remodeling complex suppresses formation of malignant rhabdoid tumors in humans and mice. Transduction of Ini1 into Ini1-deficient tumor-derived cell lines has indicated that Ini1 arrests cell growth, controls chromosomal ploidy, and suppresses tumorigenesis by regulating components of the retinoblastoma (Rb) signaling pathway. Furthermore, conditional inactivation of Ini1 in mouse fibroblasts alters the expression of various Rb-E2F-regulated genes, indicating that endogenous Ini1 levels may control Rb signaling in cells. We have reported previously that loss of one allele of Ini1 in mouse fibroblasts results only in a 15% to 20% reduction in total Ini1 mRNA levels due to transcriptional compensation by the remaining Ini1 allele. Here, we examine the effects of Ini1 haploinsufficiency on cell growth and immortalization in mouse embryonic fibroblasts. In addition, we examine pituitary tumorigenesis in Rb-Ini1 compound heterozygous mice. Our results reveal that heterozygosity for Ini1 up-regulates cell growth and immortalization and that exogenous Ini1 down-regulates the growth of primary cells in a Rb-dependent manner. Furthermore, loss of Ini1 is redundant with loss of Rb function in the formation of pituitary tumors in Rb heterozygous mice and leads to the formation of large, atypical Rb(+/-) tumor cells lacking adrenocorticotropic hormone expression. These results confirm in vivo the relationship between Rb and Ini1 in tumor suppression and indicate that Ini1 plays a role in maintaining the morphologic and functional differentiation of corticotrophic cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912184     DOI: 10.1158/0008-5472.CAN-06-1451

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

2.  CEBPD suppresses prolactin expression and prolactinoma cell proliferation.

Authors:  Yunguang Tong; Jin Zhou; Jun Mizutani; Hidenori Fukuoka; Song-Guang Ren; Arthur Gutierrez-Hartmann; H Phillip Koeffler; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2011-10-06

3.  p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.

Authors:  Sriram Venneti; Paul Le; Daniel Martinez; Katherine W Eaton; Nikhil Shyam; Kelly L Jordan-Sciutto; Bruce Pawel; Jaclyn A Biegel; Alexander R Judkins
Journal:  J Neuropathol Exp Neurol       Date:  2011-07       Impact factor: 3.685

Review 4.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

5.  Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.

Authors:  Krystal A Orlando; Vinh Nguyen; Jesse R Raab; Tara Walhart; Bernard E Weissman
Journal:  Expert Rev Anticancer Ther       Date:  2019-05-13       Impact factor: 4.512

6.  SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus.

Authors:  Sima Kheradmand Kia; Marcin M Gorski; Stavros Giannakopoulos; C Peter Verrijzer
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

7.  SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.

Authors:  Darmood Wei; Dennis Goldfarb; Shujie Song; Courtney Cannon; Feng Yan; Donastas Sakellariou-Thompson; Michael Emanuele; Michael B Major; Bernard E Weissman; Yasumichi Kuwahara
Journal:  Mol Cancer Res       Date:  2014-07-09       Impact factor: 5.852

8.  Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples.

Authors:  Heidi S Erickson; Paul S Albert; John W Gillespie; Jaime Rodriguez-Canales; W Marston Linehan; Peter A Pinto; Rodrigo F Chuaqui; Michael R Emmert-Buck
Journal:  Nat Protoc       Date:  2009-05-21       Impact factor: 13.491

9.  Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice.

Authors:  Jessica DelBove; Yasumichi Kuwahara; E Lorena Mora-Blanco; Virginia Godfrey; William K Funkhouser; Christopher D M Fletcher; Terry Van Dyke; Charles W M Roberts; Bernard E Weissman
Journal:  Mol Carcinog       Date:  2009-12       Impact factor: 4.784

Review 10.  Deregulated chromatin remodeling in the pathobiology of brain tumors.

Authors:  Anastasia Spyropoulou; Christina Piperi; Christos Adamopoulos; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2013-03       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.